72
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation

, , , , &
Pages 527-533 | Published online: 05 Apr 2016

References

  • YauJWRogersSLKawasakiRGlobal prevalence and major risk factors of diabetic retinopathyDiabetes Care201235355656422301125
  • PerenteIAlkinZOzkayaAFocal laser photocoagulation in non-center involved diabetic macular edemaMed Hypothesis Discov Innov Ophthalmol20143191624804275
  • KleinRMossSEMeuerSMKleinBEThe 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye StudyArch Ophthalmol2008126451351818413521
  • LuoXRZhengQXLiWSProgress of evidence-based medicine study of central retinal vein occlusionChin J Pract Ophthalmol2011292103109
  • RiiTItohYInoueMHirakataAFoveal cone outer segment tips line and disruption artifacts in spectral-domain optical coherence tomographic images of normal eyesAm J Ophthalmol201215352452922018706
  • ZhengZPrevention and treatment of diabetic retinopathy: progress, challenges, and future prospectsChin J Ocul Fundus Dis2012283209214
  • NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: Rise and RideOphthalmology2012119478980122330964
  • TitchenellPMAntonettiDAUsing the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathyDiabetes20136261808181523704522
  • BrownDMNguyenQDMarcusDMLong-term outcomes of ranbizumab therapy for diabetic macular edema: the 36-month results from two phase III trials RISE and RIDEOphthalmology2013120102013202223706949
  • HuaWCaoSCuiJMaberleyDMatsubaraJAnalysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathyCan J Ophthalmol2013482889223561600
  • StewartMWCritical appraisal of ranibizumab in the treatment of diabetic macular edemaClin Ophthalmol201371257126723836955
  • SrinivasanVJMonsonBKWojtkowskiMCharacterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomographyInvest Ophthalmol Vis Sci20084941571158018385077
  • AiHYangXGExpression of VEGF and IL-6 in atria and vitreous cavity of patients with central retinal vein occlusion macular edemaChin J Cell Mol Immunol20112711241126
  • PaulusYMGarianoRFDiabetic retinopathy: a growing concern in an aging populationGeriatrics2009642162019256582
  • NicholsonBPSchachatAPA review of clinical trials of anti-VEGF agents for diabetic retinopathyGraefes Arch Clin Exp Ophthalmol2010248791593020174816
  • DoDVNguyenQDKhwajaAARanibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatmentJAMA Ophthalmol2013131213914523544200
  • CiullaTACriswellMHDanisRPHillTEIntravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-related rat modelArch Ophthalmol2001119239934011231773
  • BenhamouNMassiaPHaouchineBAudrenFTadayoniRGaudricAIntravitreal triamcinolone for refractory pseudophakic macular edemaAm J Ophthalmol200313524624912566041
  • LimaVCYeungLCastroLCLandaGRosenRBCorrelation between spectral domain optical coherence tomography findings and visual out-comes in central retinal vein occlusionClin Ophthalmol2011529930521468337
  • MitchellPBandelloFSchmidt-ErfurthUThe restore study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215